Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026)
Zoetis' (ZTS) quarterly Other Accumulated Expenses came in at $856.0 million in Q2 2026, up 11.17% year-over-year from $770.0 million in Q2 2025, and up 13.98% quarter-over-quarter from $751.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Other Accumulated Expenses for 14 consecutive years, with $856.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Accumulated Expenses rose 11.17% year-over-year to $856.0 million in Q2 2026; TTM through Jun 2026 was $856.0 million, a 11.17% increase from a year earlier, with the FY2025 full-year figure at $841.0 million, up 572.8% from the prior year.
- Other Accumulated Expenses was $856.0 million for Q2 2026 at Zoetis, up from $751.0 million in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $856.0 million in Q2 2026 and troughed at $97.0 million in Q4 2022.
- A 5-year average of $628.4 million and a median of $698.5 million in 2022 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses soared 572.8% in 2025 and decreased 2.72% in 2026, its largest moves.
- Over 5 years, Other Accumulated Expenses stood at $97.0 million in 2022, then climbed by 5.15% to $102.0 million in 2023, then gained by 22.55% to $125.0 million in 2024, then soared by 572.8% to $841.0 million in 2025, then advanced by 1.78% to $856.0 million in 2026.
- The last three Other Accumulated Expenses figures came in at $856.0 million (Q2 2026), $751.0 million (Q1 2026), and $841.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.57 Bn | 40.38 Bn | 779.09 Mn |
| 2 | Zoetis | 30.57 Bn | 28.90 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.47 Bn | 10.94 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 134.40 Mn |
| 5 | Immucell | 87.38 Mn | 78.52 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 64.40 Mn | 57.30 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 856.00 Mn |
| Mar 31, 2026 | 751.00 Mn |
| Dec 31, 2025 | 841.00 Mn |
| Sep 30, 2025 | 809.00 Mn |
| Jun 30, 2025 | 770.00 Mn |
| Mar 31, 2025 | 772.00 Mn |
| Dec 31, 2024 | 125.00 Mn |
| Sep 30, 2024 | 725.00 Mn |
| Jun 30, 2024 | 704.00 Mn |
| Mar 31, 2024 | 691.00 Mn |
| Dec 31, 2023 | 102.00 Mn |
| Sep 30, 2023 | 693.00 Mn |
| Jun 30, 2023 | 689.00 Mn |
| Mar 31, 2023 | 701.00 Mn |
| Dec 31, 2022 | 97.00 Mn |
| Sep 30, 2022 | 679.00 Mn |
| Jun 30, 2022 | 696.00 Mn |
| Mar 31, 2022 | 610.00 Mn |
| Dec 31, 2021 | 67.00 Mn |
| Sep 30, 2021 | 618.00 Mn |